Oxford Nanopore wins injunction against MGI Tech in patent case
Munich - Oxford Nanopore Technologies has secured a preliminary injunction against MGI Tech GmbH, preventing the company from manufacturing, marketing, or using its CycloneSEQ sequencing platform. This ban applies to the CycloneSEQ-WT02, CycloneSEQ-WY01, G100-ER, and G400-ER systems, as well as any devices utilizing similar sequencing technology.
The injunction extends to Denmark, France, Germany, the Netherlands, Liechtenstein, Switzerland, the UK, and Ireland, with a limited scope in Ireland to Cyclone Sequencing Systems paired with a specific flow cell. MGI Tech faces potential penalties for any violations of the injunction, which will remain enforceable until the possibility of an appeal.
Oxford Nanopore plans to pursue a permanent injunction and has set a trial hearing for October 2027. The company specializes in nanopore-based molecular sensing technology.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
